We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Illumina

Illumina develops, manufactures and markets integrated systems for the analysis of genetic variations and biological ... read more Featured Products: More products

Download Mobile App




Extrachromosomal Circular DNA Identified in Maternal Plasma

By LabMedica International staff writers
Posted on 16 Jan 2020
Circular cell-free DNA of both maternal and fetal origin can be identified in the plasma of pregnant women, pointing to a possible new type of biomarker for noninvasive prenatal testing (NIPT).

Linear cell-free DNA from maternal plasma has long formed the basis of NIPT for fetal aneuploidies. More...
While extrachromosomal circular DNA (eccDNA) in plasma, which could be more resistant to exonucleases and therefore more stable than linear circulating DNA, has been observed in people before, it has not been reported in pregnant women.

Scientists from the Chinese University of Hong Kong (Shatin, N.T., Hong Kong, China) and their associates analyzed plasma DNA from five pregnant women. After enriching for circular DNA, they linearized and sequenced the eccDNA molecules. Through sequencing following either restriction enzyme or Tn5 transposase treatment, they identified eccDNA molecules in the plasma of pregnant women.

The team reported that the eccDNA molecules showed bimodal size distributions peaking at ∼202 and ∼338 bp with distinct 10-bp periodicity observed throughout the size ranges within both peaks, suggestive of their nucleosomal origin. Also, the predominance of the 338-bp peak of eccDNA indicated that eccDNA had a larger size distribution than linear DNA in human plasma. Moreover, eccDNA of fetal origin were shorter than the maternal eccDNA.

Fetal-origin eccDNA molecules were generally shorter than those of maternal origin, averaging around 202 base pairs in size, while maternal eccDNA averaged around 338 base pairs. This, the team noted, was consistent with what has been observed in linear fetal and maternal cell-free DNA. However, the MspI digestion for linearization they relied on might have affected the portion of eccDNAs that could be analyzed. To confirm their findings, they also used a tagmentation-based approach to isolate and analyze eccDNAs from another set of five pregnant women. For tagmentation-based approach, circular DNA enriched from 25 ng of plasma DNA were processed using Nextera XT DNA Library Preparation Kit (Illumina, San Diego, CA, USA). DNA libraries were sequenced on Illumina HiSeq 1500/2500 platforms in Rapid Run mode. All libraries were sequenced as 2 × 250-bp paired-end reads.

By mapping the eccDNAs back to the genome, the scientists found they were enriched in 5'-untranslated, exonic, and CpG island regions, indicating that circular DNAs are not randomly generated from the genome. There were also recurrent patterns within eccDNAs: both the start and end positions are flanked by pairs of trinucleotide segments with four-base spacers. Further analysis of these patterns hinted that homologous recombination and microhomology-mediated end joining could serve as the mechanisms through which eccDNAs are formed from double-stranded DNA. EccDNA molecules from maternal plasma could ultimately serve as biomarkers, they suggested, with the added potential benefit of circular DNA being more robust than linear DNA.

The scientists concluded that eccDNA in maternal plasma with their increased biostability and distinct molecular signatures might add to the toolbox of the rapidly developing field of noninvasive prenatal testing. It would be interesting for future studies to explore the potential aberrations of maternal plasma eccDNA profiles in different pregnancy-associated disorders, such as preeclampsia and preterm birth.” The study was published on January 3, 2020 in the journal Proceedings of the National Academy of Sciences.

Related Links:
Chinese University of Hong Kong
Illumina


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Manual Pipetting Aid
Pipette Controllers macro
New
Portable POCT Blood Gas Analyzer
BD100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: The “broth” used to monitor red blood cell depletion in whole blood spiked with one colony-forming-unit of E. coli bacteria, each incubated at different orbital shaking speeds—left to right: 0 RPM, 65 RPM, 120 RPM and 200 RPM—after four hours of incubation. This culturing raises a bacteria-rich, plasma-like layer of bacteria to the top of the vials, while clusters of stuck blood cells known as a Rouleaux formation sink to the bottom. (Image Credit: Pak Kin Wong)

New Diagnostic Workflow Identifies Bloodstream Pathogens and Antibiotic Response in Hours

Sepsis is a life-threatening complication of infection that affects more than 1.5 million patients annually in the United States and contributes to roughly one in three in-hospital deaths.... Read more

Pathology

view channel
Image: Researchers evaluated AI models that quantify tumor-infiltrating lymphocytes (TIL) on routine breast tissue slides, where higher TIL levels reflect stronger antitumor response and improved breast cancer outcomes (Image Credit: Shutterstock)

AI Matches Pathologists in Predicting Breast Cancer Prognosis from Immune Cells

Breast cancer is the most common cancer in Australian women, with more than 20,000 cases each year. Prognosis can be informed by counting tumor-infiltrating lymphocytes (TILs) on routine pathology slides,... Read more

Industry

view channel
Image: RaDaR ST uses a tumor-informed approach that identifies up to 48 patient-specific variants through whole-exome sequencing and tracks those variants in plasma to detect circulating tumor DNA (ctDNA) at very low variant allele fractions (VAFs) (Photo courtesy of Neogenomics)

Tumor-Informed MRD Assay Gains Medicare Coverage for Immunotherapy Monitoring

NeoGenomics’ RaDaR ST molecular residual disease (MRD) assay has received expanded coverage from the Centers for Medicare & Medicaid Services’ Molecular Diagnostic Services Program (MolDX) for monitoring... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.